Your browser doesn't support javascript.
loading
Inflammation, immunity, and antigen persistence in post-acute sequelae of SARS-CoV-2 infectionImmunity and inflammaion in post-acute sequelae of SARS-CoV-2 infection.
Newell, Krista L; Waickman, Adam T.
Affiliation
  • Newell KL; Department of Microbiology and Immunology, SUNY Upstate Medical University, Syracuse, NY, United States.
  • Waickman AT; Department of Microbiology and Immunology, SUNY Upstate Medical University, Syracuse, NY, United States; Institute for Global Health and Translational Science, SUNY Upstate Medical University, Syracuse, NY, United States. Electronic address: waickmaa@upstate.edu.
Curr Opin Immunol ; 77: 102228, 2022 08.
Article in En | MEDLINE | ID: mdl-35724449
ABSTRACT
SARS-CoV-2 infection is known to result in a range of symptoms with varying degrees of acute-phase severity. In a subset of individuals, an equally diverse collection of long-term sequelae has been reported after convalescence. As survivorship and therefore the number of individuals with 'long-COVID' continues to grow, an understanding of the prevalence, origins, and mechanisms of post-acute sequelae manifestation is critically needed. Here, we will explore proposed roles of the anti-SARS-CoV-2 immune response in the onset, severity, and persistence of SARS-CoV-2 post-acute sequelae. We discuss the potential roles of persistent virus and autoantigens in this syndrome, as well as the contributions of unresolved inflammation and tissue injury. Furthermore, we highlight recent evidence demonstrating the potential benefits of vaccination and immunity in the resolution of post-acute symptoms.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Curr Opin Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 2022 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Curr Opin Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 2022 Document type: Article Affiliation country: United States